Related Experiment Video
Updated: Feb 13, 2026

Best Current Practice for Obtaining High Quality EEG Data During Simultaneous fMRI
Published on: June 3, 2013
Evaluating Data Quality by Proxy: Can We Evaluate All Dimensions of the European Medicines Agency Data Quality
Pamela Dobay1, Meritxell Sabidó2
1Statistical Sciences and Evidence Generation, Biogen International GmbH, Baar, Switzerland.
Purpose:
An increasing number of studies based on secondary data use, including registry-based studies, have been initiated to address post-authorization regulatory commitments. We map differences across tools used in data quality (DQ) assessments, including those embedded in fitness-for-purpose (FFP) assessments, and describe their strengths and limitations for use in DQ assessments of registries considered for use in post-approval safety studies (PASS). We focus on the use case where marketing authorization holders (MAHs) cannot directly analyze patient-level data. Furthermore, we propose complementary measures to improve DQ assessment, including a set of data quality indicators (DQIs).
Methods:
We analyzed the extent to which the selected tools used in registry assessments address DQ dimensions and metrics defined in the European Medicines Agency-DQ Framework (EMA-DQF). We specifically considered the use case where DQ assessment was purely based on registry documentation and qualitative due to data access restrictions.
Results:
None of the tools covered all DQ dimensions and metrics; they had limited utility for evaluating extensiveness (i.e., completeness and coverage), semantic coherence, and reliability (i.e., accuracy and plausibility). Furthermore, some supporting document requirements were more useful than others. For example, the data dictionary is useful for evaluating precision and structural coherence. In contrast, publications have limited utility in DQ assessment.
Conclusions:
We propose a set of consistent definitions of information requirements and quantitative DQIs that complement existing tools that can be used for evaluating DQ throughout the registry-based PASS lifecycle. If DQIs cannot be evaluated during the preparation of the PASS protocol, uncertainties and their potential impact on the study results need to be acknowledged in the relevant study documents. Additionally, scenario mapping for the removal or replacement of registries with insufficient DQ after PASS initiation is needed.
Related Concept Videos
Quality Control
Quality control helps track data, visualize trends, and identify variations, making it easier to detect deviations that may affect the accuracy of an analysis. One way to do this is by generating a quality control chart, which...
Quality Assurance
Quality of Water
How Data are Classified: Categorical Data
Data are classified based on whether they are measurable or not. Categorical data cannot be measured; instead, it can be divided into categories. For example, if Y denotes a person's party affiliation, some examples of Y include...
How Data are Classified: Numerical Data
Quantitative data may be either discrete or continuous. All quantitative data that take on only specific numerical...
Pulse amplitude and quality
A weak or absent pulse may indicate reduced cardiac output or poor left ventricular contraction, which can be signs of cardiovascular dysfunction or...

